YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Valeant Pharma Buys Bausch & Lomb


May 28, 2013 | Valeant Pharmaceuticals International of Canada has purchased Bausch & Lomb, the eye care company, for about $8.7 billion. Valeant will pay $4.5 billion to the investor group that owns Bausch & Lomb, and about $4.2 billion to repay Bausch & Lomb’s debt. New York Times Dealbook
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.